Robert Ryu
Concepts (501)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 24 | 2023 | 68 | 6.110 |
Why?
| | Embolization, Therapeutic | 44 | 2020 | 246 | 3.120 |
Why?
| | Liver Neoplasms | 60 | 2014 | 774 | 3.020 |
Why?
| | Device Removal | 18 | 2023 | 149 | 2.980 |
Why?
| | Yttrium Radioisotopes | 40 | 2020 | 64 | 2.710 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 10 | 2021 | 37 | 2.700 |
Why?
| | Carcinoma, Hepatocellular | 41 | 2014 | 369 | 2.380 |
Why?
| | Radiology, Interventional | 6 | 2024 | 49 | 2.290 |
Why?
| | Pulmonary Embolism | 11 | 2021 | 245 | 1.770 |
Why?
| | Radiography, Interventional | 17 | 2016 | 127 | 1.530 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 34 | 1.450 |
Why?
| | Chemoembolization, Therapeutic | 21 | 2014 | 88 | 1.420 |
Why?
| | Hypertension, Portal | 5 | 2016 | 66 | 1.250 |
Why?
| | Radiopharmaceuticals | 19 | 2020 | 210 | 1.220 |
Why?
| | Lumbar Vertebrae | 4 | 2021 | 259 | 1.170 |
Why?
| | Uterine Neoplasms | 11 | 2010 | 98 | 1.070 |
Why?
| | Vena Cava, Inferior | 7 | 2021 | 79 | 0.980 |
Why?
| | Educational Measurement | 2 | 2020 | 329 | 0.940 |
Why?
| | Venous Thrombosis | 6 | 2023 | 195 | 0.930 |
Why?
| | Lasers, Excimer | 2 | 2022 | 30 | 0.900 |
Why?
| | Renal Dialysis | 2 | 2020 | 458 | 0.870 |
Why?
| | Treatment Outcome | 71 | 2023 | 11744 | 0.850 |
Why?
| | Practice Patterns, Physicians' | 9 | 2021 | 1370 | 0.850 |
Why?
| | Portal Vein | 4 | 2016 | 120 | 0.840 |
Why?
| | Microspheres | 29 | 2013 | 142 | 0.830 |
Why?
| | Prosthesis Design | 7 | 2020 | 357 | 0.790 |
Why?
| | Magnetic Resonance Imaging, Interventional | 8 | 2014 | 30 | 0.760 |
Why?
| | Specialty Boards | 2 | 2020 | 41 | 0.750 |
Why?
| | Leiomyoma | 9 | 2007 | 62 | 0.750 |
Why?
| | Total Disc Replacement | 2 | 2020 | 11 | 0.740 |
Why?
| | Intervertebral Disc | 3 | 2020 | 35 | 0.730 |
Why?
| | Uterus | 7 | 2007 | 227 | 0.720 |
Why?
| | End Stage Liver Disease | 2 | 2021 | 78 | 0.710 |
Why?
| | Forecasting | 1 | 2024 | 386 | 0.710 |
Why?
| | Postoperative Complications | 8 | 2021 | 2962 | 0.700 |
Why?
| | Venous Insufficiency | 3 | 2007 | 12 | 0.680 |
Why?
| | Saphenous Vein | 3 | 2007 | 36 | 0.670 |
Why?
| | Thromboembolism | 3 | 2017 | 129 | 0.650 |
Why?
| | Middle Aged | 87 | 2026 | 36359 | 0.620 |
Why?
| | Spinal Fusion | 3 | 2021 | 264 | 0.610 |
Why?
| | Humans | 152 | 2026 | 145625 | 0.610 |
Why?
| | Prosthesis Implantation | 3 | 2017 | 155 | 0.600 |
Why?
| | Medicare | 3 | 2020 | 907 | 0.600 |
Why?
| | Intervertebral Disc Displacement | 1 | 2020 | 40 | 0.590 |
Why?
| | Diagnostic Imaging | 4 | 2024 | 340 | 0.590 |
Why?
| | Laser Therapy | 3 | 2007 | 146 | 0.580 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2020 | 70 | 0.570 |
Why?
| | Graft Occlusion, Vascular | 2 | 2018 | 39 | 0.560 |
Why?
| | Medicine | 1 | 2020 | 126 | 0.560 |
Why?
| | Magnetic Resonance Angiography | 10 | 2014 | 249 | 0.560 |
Why?
| | Endovascular Procedures | 5 | 2020 | 385 | 0.550 |
Why?
| | Low Back Pain | 1 | 2020 | 108 | 0.550 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 20 | 0.530 |
Why?
| | Venous Thromboembolism | 4 | 2017 | 330 | 0.530 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2019 | 217 | 0.520 |
Why?
| | Ultrasonography, Interventional | 3 | 2016 | 163 | 0.510 |
Why?
| | Spine | 1 | 2019 | 184 | 0.510 |
Why?
| | Ascites | 2 | 2016 | 47 | 0.500 |
Why?
| | Time Factors | 25 | 2021 | 7079 | 0.500 |
Why?
| | Female | 103 | 2026 | 79080 | 0.500 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 74 | 0.500 |
Why?
| | Magnetic Resonance Imaging | 27 | 2023 | 3917 | 0.490 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2021 | 133 | 0.490 |
Why?
| | Tomography, X-Ray Computed | 25 | 2026 | 2766 | 0.480 |
Why?
| | Stents | 8 | 2015 | 551 | 0.470 |
Why?
| | Aged | 64 | 2026 | 26251 | 0.470 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 252 | 0.470 |
Why?
| | Retrospective Studies | 37 | 2023 | 17291 | 0.460 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2016 | 33 | 0.450 |
Why?
| | Digestive System Neoplasms | 1 | 2015 | 9 | 0.450 |
Why?
| | Brachytherapy | 8 | 2008 | 132 | 0.440 |
Why?
| | Aged, 80 and over | 34 | 2021 | 8351 | 0.440 |
Why?
| | Male | 88 | 2026 | 73014 | 0.430 |
Why?
| | Cholestasis | 2 | 2015 | 215 | 0.430 |
Why?
| | Social Media | 1 | 2017 | 158 | 0.430 |
Why?
| | Adult | 59 | 2021 | 40821 | 0.420 |
Why?
| | United States | 17 | 2026 | 16041 | 0.410 |
Why?
| | Radiology | 2 | 2024 | 175 | 0.400 |
Why?
| | Radiation Dosage | 6 | 2020 | 193 | 0.390 |
Why?
| | Liver Neoplasms, Experimental | 4 | 2020 | 26 | 0.370 |
Why?
| | Thrombosis | 4 | 2022 | 397 | 0.360 |
Why?
| | Ovary | 3 | 2003 | 235 | 0.350 |
Why?
| | Clinical Competence | 2 | 2019 | 1261 | 0.350 |
Why?
| | Angiography | 11 | 2011 | 206 | 0.340 |
Why?
| | Imaging, Three-Dimensional | 5 | 2011 | 578 | 0.340 |
Why?
| | Liver Cirrhosis | 6 | 2019 | 276 | 0.330 |
Why?
| | Risk Factors | 18 | 2020 | 10840 | 0.320 |
Why?
| | Uterine Artery Embolization | 1 | 2010 | 9 | 0.310 |
Why?
| | Vascular System Injuries | 3 | 2016 | 79 | 0.310 |
Why?
| | Perfusion Imaging | 1 | 2010 | 66 | 0.310 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2021 | 236 | 0.310 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 110 | 0.300 |
Why?
| | Angioplasty | 3 | 2007 | 48 | 0.300 |
Why?
| | Drainage | 3 | 2019 | 187 | 0.300 |
Why?
| | Chicago | 6 | 2017 | 62 | 0.300 |
Why?
| | Adenoma, Islet Cell | 1 | 2009 | 6 | 0.300 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2007 | 162 | 0.300 |
Why?
| | Liver Abscess | 1 | 2009 | 3 | 0.300 |
Why?
| | Predictive Value of Tests | 11 | 2020 | 2097 | 0.290 |
Why?
| | Observer Variation | 3 | 2010 | 355 | 0.290 |
Why?
| | Polyvinyl Alcohol | 3 | 2005 | 19 | 0.290 |
Why?
| | Thyroid Gland | 1 | 2009 | 93 | 0.290 |
Why?
| | Hepatic Veins | 1 | 2008 | 28 | 0.280 |
Why?
| | Rabbits | 12 | 2020 | 647 | 0.280 |
Why?
| | Phlebography | 6 | 2015 | 38 | 0.280 |
Why?
| | Contrast Media | 12 | 2016 | 492 | 0.270 |
Why?
| | Neoplasms | 5 | 2023 | 2944 | 0.270 |
Why?
| | Liver Transplantation | 5 | 2015 | 699 | 0.270 |
Why?
| | Neovascularization, Pathologic | 5 | 2009 | 285 | 0.270 |
Why?
| | Gelatin | 2 | 2005 | 56 | 0.270 |
Why?
| | Portography | 4 | 2016 | 7 | 0.270 |
Why?
| | Lymphangioma, Cystic | 1 | 2007 | 5 | 0.260 |
Why?
| | Databases, Factual | 7 | 2020 | 1481 | 0.250 |
Why?
| | Prosthesis Failure | 3 | 2017 | 125 | 0.250 |
Why?
| | Catheterization | 7 | 2013 | 178 | 0.250 |
Why?
| | Aortography | 1 | 2007 | 52 | 0.250 |
Why?
| | Patient Selection | 6 | 2020 | 720 | 0.250 |
Why?
| | Pancreatic Neoplasms | 3 | 2010 | 944 | 0.250 |
Why?
| | Antineoplastic Agents | 6 | 2014 | 2218 | 0.250 |
Why?
| | Logistic Models | 8 | 2021 | 2112 | 0.240 |
Why?
| | Hepatic Artery | 5 | 2010 | 52 | 0.240 |
Why?
| | Linear Models | 4 | 2017 | 847 | 0.240 |
Why?
| | Thrombolytic Therapy | 4 | 2023 | 165 | 0.240 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 132 | 0.240 |
Why?
| | Referral and Consultation | 1 | 2012 | 878 | 0.230 |
Why?
| | Acrylic Resins | 1 | 2005 | 48 | 0.220 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 380 | 0.220 |
Why?
| | Radiation Injuries | 5 | 2010 | 149 | 0.220 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2007 | 218 | 0.220 |
Why?
| | Blister | 1 | 2004 | 38 | 0.210 |
Why?
| | Arteries | 7 | 2013 | 260 | 0.200 |
Why?
| | Multivariate Analysis | 7 | 2017 | 1531 | 0.200 |
Why?
| | Prospective Studies | 17 | 2026 | 8087 | 0.200 |
Why?
| | Survival Rate | 12 | 2018 | 2078 | 0.200 |
Why?
| | Cohort Studies | 7 | 2023 | 6045 | 0.200 |
Why?
| | Internship and Residency | 2 | 2019 | 1269 | 0.200 |
Why?
| | Postphlebitic Syndrome | 1 | 2023 | 3 | 0.190 |
Why?
| | Postthrombotic Syndrome | 1 | 2023 | 13 | 0.190 |
Why?
| | Jugular Veins | 3 | 1997 | 41 | 0.190 |
Why?
| | Neoplasm Staging | 8 | 2014 | 1486 | 0.180 |
Why?
| | Fluoroscopy | 2 | 2016 | 177 | 0.180 |
Why?
| | Elasticity Imaging Techniques | 1 | 2022 | 59 | 0.180 |
Why?
| | Catheters | 3 | 2023 | 71 | 0.180 |
Why?
| | Education, Medical, Continuing | 2 | 2017 | 130 | 0.180 |
Why?
| | Neoplasms, Experimental | 2 | 2013 | 163 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 9 | 2015 | 959 | 0.170 |
Why?
| | Chi-Square Distribution | 6 | 2014 | 511 | 0.170 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 1062 | 0.170 |
Why?
| | Disease Progression | 14 | 2014 | 2857 | 0.170 |
Why?
| | Constriction, Pathologic | 3 | 2019 | 238 | 0.170 |
Why?
| | Vascular Patency | 3 | 2018 | 115 | 0.170 |
Why?
| | Bone-Implant Interface | 1 | 2021 | 3 | 0.170 |
Why?
| | Angiography, Digital Subtraction | 6 | 2014 | 51 | 0.170 |
Why?
| | Liver | 7 | 2013 | 1859 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 413 | 0.160 |
Why?
| | Ultrasonography, Doppler, Color | 3 | 2008 | 36 | 0.160 |
Why?
| | alpha-Fetoproteins | 2 | 2012 | 42 | 0.160 |
Why?
| | Surgical Stomas | 1 | 2000 | 10 | 0.160 |
Why?
| | Reoperation | 4 | 2019 | 633 | 0.160 |
Why?
| | Liver Diseases | 2 | 2007 | 298 | 0.160 |
Why?
| | Colostomy | 1 | 2000 | 28 | 0.160 |
Why?
| | Varicose Veins | 1 | 2000 | 16 | 0.160 |
Why?
| | Adolescent | 16 | 2021 | 22451 | 0.160 |
Why?
| | Early Detection of Cancer | 1 | 2026 | 501 | 0.160 |
Why?
| | Disease Models, Animal | 6 | 2016 | 4565 | 0.160 |
Why?
| | Catheter Ablation | 1 | 2004 | 355 | 0.160 |
Why?
| | Sensitivity and Specificity | 9 | 2012 | 1992 | 0.160 |
Why?
| | Infusions, Intra-Arterial | 9 | 2010 | 61 | 0.160 |
Why?
| | Medical Oncology | 2 | 2013 | 344 | 0.160 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 216 | 0.150 |
Why?
| | Lumbosacral Region | 1 | 2020 | 58 | 0.150 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2020 | 122 | 0.150 |
Why?
| | Budd-Chiari Syndrome | 1 | 1999 | 5 | 0.150 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 14 | 0.150 |
Why?
| | Laminoplasty | 1 | 2019 | 3 | 0.150 |
Why?
| | Laminectomy | 1 | 2019 | 30 | 0.150 |
Why?
| | Bile Ducts | 1 | 2019 | 65 | 0.140 |
Why?
| | Follow-Up Studies | 11 | 2013 | 5397 | 0.140 |
Why?
| | Iliac Artery | 2 | 2018 | 52 | 0.140 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2011 | 295 | 0.140 |
Why?
| | Specialization | 1 | 2020 | 136 | 0.140 |
Why?
| | Ohio | 1 | 2019 | 136 | 0.140 |
Why?
| | Glass | 3 | 2013 | 46 | 0.140 |
Why?
| | Hemorrhage | 2 | 2023 | 824 | 0.140 |
Why?
| | Models, Educational | 1 | 2019 | 90 | 0.140 |
Why?
| | Survival Analysis | 6 | 2011 | 1372 | 0.140 |
Why?
| | Young Adult | 8 | 2021 | 14240 | 0.140 |
Why?
| | Biliary Fistula | 1 | 1998 | 4 | 0.140 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 204 | 0.140 |
Why?
| | Urinary Fistula | 1 | 1998 | 12 | 0.130 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2010 | 158 | 0.130 |
Why?
| | Intestine, Small | 1 | 2019 | 160 | 0.130 |
Why?
| | Fibrin | 2 | 2023 | 84 | 0.130 |
Why?
| | Mesenteric Veins | 1 | 1998 | 28 | 0.130 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 269 | 0.130 |
Why?
| | Pain | 1 | 2003 | 787 | 0.130 |
Why?
| | Writing | 1 | 2019 | 101 | 0.130 |
Why?
| | Thrombectomy | 1 | 1998 | 79 | 0.130 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 207 | 0.130 |
Why?
| | Liver Circulation | 4 | 2015 | 12 | 0.130 |
Why?
| | Radiography | 7 | 2012 | 856 | 0.130 |
Why?
| | Treatment Failure | 4 | 2017 | 358 | 0.130 |
Why?
| | Longitudinal Studies | 2 | 2026 | 3005 | 0.130 |
Why?
| | Patient Advocacy | 1 | 2017 | 73 | 0.120 |
Why?
| | Drug Utilization | 1 | 2017 | 170 | 0.120 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 25 | 0.120 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 25 | 0.120 |
Why?
| | Portal Pressure | 1 | 2016 | 4 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2910 | 0.120 |
Why?
| | History, 20th Century | 1 | 2017 | 330 | 0.120 |
Why?
| | Hospitals | 1 | 2021 | 730 | 0.120 |
Why?
| | Anatomic Landmarks | 1 | 2016 | 31 | 0.120 |
Why?
| | Finite Element Analysis | 1 | 2016 | 67 | 0.120 |
Why?
| | Balloon Occlusion | 1 | 2016 | 39 | 0.120 |
Why?
| | Research Design | 3 | 2013 | 1139 | 0.120 |
Why?
| | Gadolinium DTPA | 5 | 2014 | 70 | 0.110 |
Why?
| | Lower Extremity | 1 | 2020 | 449 | 0.110 |
Why?
| | Academic Medical Centers | 1 | 2019 | 560 | 0.110 |
Why?
| | Cell Line, Tumor | 7 | 2013 | 3538 | 0.110 |
Why?
| | Stomach | 2 | 2013 | 106 | 0.110 |
Why?
| | Reproducibility of Results | 8 | 2011 | 3396 | 0.110 |
Why?
| | Models, Anatomic | 1 | 2016 | 87 | 0.110 |
Why?
| | Patient Readmission | 1 | 2021 | 771 | 0.110 |
Why?
| | Radiation Exposure | 1 | 2016 | 62 | 0.110 |
Why?
| | Operative Time | 1 | 2016 | 192 | 0.110 |
Why?
| | Doxorubicin | 3 | 2013 | 414 | 0.110 |
Why?
| | Bile Ducts, Intrahepatic | 3 | 2013 | 62 | 0.110 |
Why?
| | Wounds, Nonpenetrating | 4 | 2000 | 304 | 0.110 |
Why?
| | Biomarkers, Tumor | 4 | 2026 | 1334 | 0.110 |
Why?
| | Necrosis | 5 | 2020 | 243 | 0.110 |
Why?
| | Aorta | 1 | 2018 | 440 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2016 | 154 | 0.110 |
Why?
| | Dilatation | 1 | 2015 | 73 | 0.110 |
Why?
| | Biopsy | 3 | 2014 | 1073 | 0.110 |
Why?
| | Hospital Mortality | 2 | 2018 | 1037 | 0.110 |
Why?
| | Sex Factors | 2 | 2018 | 2101 | 0.110 |
Why?
| | Data Interpretation, Statistical | 3 | 2013 | 365 | 0.100 |
Why?
| | Carotid Artery Injuries | 3 | 2000 | 39 | 0.100 |
Why?
| | Cisplatin | 3 | 2012 | 346 | 0.100 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 32 | 0.100 |
Why?
| | Wounds, Gunshot | 1 | 1998 | 257 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2016 | 228 | 0.100 |
Why?
| | Length of Stay | 2 | 2019 | 1342 | 0.100 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 566 | 0.100 |
Why?
| | Stress, Mechanical | 1 | 2016 | 493 | 0.100 |
Why?
| | Kidney Diseases | 1 | 1998 | 427 | 0.100 |
Why?
| | Magnetite Nanoparticles | 1 | 2013 | 27 | 0.100 |
Why?
| | Duodenum | 1 | 2013 | 76 | 0.100 |
Why?
| | Ultrasonography | 3 | 2022 | 788 | 0.100 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 506 | 0.090 |
Why?
| | Arthroscopy | 3 | 1992 | 268 | 0.090 |
Why?
| | Prevalence | 3 | 2021 | 2852 | 0.090 |
Why?
| | Anticoagulants | 2 | 2017 | 743 | 0.090 |
Why?
| | Catheterization, Peripheral | 3 | 2008 | 113 | 0.090 |
Why?
| | Regional Blood Flow | 3 | 2007 | 507 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2017 | 769 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2026 | 2674 | 0.090 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 868 | 0.090 |
Why?
| | Proportional Hazards Models | 5 | 2014 | 1318 | 0.090 |
Why?
| | Shoulder Injuries | 1 | 1992 | 66 | 0.090 |
Why?
| | Acromion | 1 | 1992 | 8 | 0.090 |
Why?
| | Electroporation | 1 | 2012 | 43 | 0.090 |
Why?
| | Tendon Injuries | 1 | 1992 | 73 | 0.090 |
Why?
| | Fibromuscular Dysplasia | 1 | 2011 | 8 | 0.090 |
Why?
| | Respiratory-Gated Imaging Techniques | 1 | 2011 | 10 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1996 | 0.090 |
Why?
| | Rotator Cuff | 1 | 1992 | 61 | 0.080 |
Why?
| | Comorbidity | 1 | 2016 | 1652 | 0.080 |
Why?
| | Animals | 15 | 2021 | 38030 | 0.080 |
Why?
| | Yttrium | 1 | 2010 | 5 | 0.080 |
Why?
| | Prognosis | 5 | 2010 | 4331 | 0.080 |
Why?
| | Research Report | 1 | 2011 | 89 | 0.080 |
Why?
| | Injections, Intra-Arterial | 5 | 2012 | 25 | 0.080 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 86 | 0.080 |
Why?
| | Tumor Burden | 3 | 2020 | 326 | 0.080 |
Why?
| | Punctures | 1 | 2010 | 40 | 0.080 |
Why?
| | Practice Guidelines as Topic | 5 | 2013 | 1581 | 0.080 |
Why?
| | Neuroendocrine Tumors | 1 | 2011 | 122 | 0.080 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 79 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2014 | 473 | 0.070 |
Why?
| | Recurrence | 3 | 2021 | 1125 | 0.070 |
Why?
| | Gastrostomy | 2 | 2009 | 123 | 0.070 |
Why?
| | Pancreatic Pseudocyst | 1 | 2009 | 18 | 0.070 |
Why?
| | Bilirubin | 3 | 2010 | 101 | 0.070 |
Why?
| | Liver Function Tests | 3 | 2015 | 103 | 0.070 |
Why?
| | Radiation Pneumonitis | 1 | 2008 | 31 | 0.070 |
Why?
| | Biliary Tract | 1 | 2008 | 13 | 0.070 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2411 | 0.070 |
Why?
| | Radiotherapy Dosage | 4 | 2010 | 289 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 267 | 0.070 |
Why?
| | Knee Injuries | 1 | 1989 | 121 | 0.070 |
Why?
| | Maximum Allowable Concentration | 1 | 2007 | 15 | 0.070 |
Why?
| | Subtraction Technique | 1 | 2007 | 26 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 238 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1500 | 0.070 |
Why?
| | Endpoint Determination | 3 | 2013 | 84 | 0.060 |
Why?
| | Vacuum Curettage | 1 | 2007 | 4 | 0.060 |
Why?
| | Ultrasonography, Doppler, Duplex | 2 | 2004 | 39 | 0.060 |
Why?
| | Acute Disease | 2 | 2021 | 1033 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2008 | 178 | 0.060 |
Why?
| | Image Enhancement | 4 | 2011 | 198 | 0.060 |
Why?
| | Incidence | 3 | 2009 | 2910 | 0.060 |
Why?
| | Radiotherapy | 1 | 2008 | 209 | 0.060 |
Why?
| | Leiomyomatosis | 1 | 2006 | 4 | 0.060 |
Why?
| | Credentialing | 1 | 2006 | 21 | 0.060 |
Why?
| | Palliative Care | 1 | 2015 | 1032 | 0.060 |
Why?
| | Catheterization, Central Venous | 2 | 1999 | 120 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 339 | 0.060 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 299 | 0.060 |
Why?
| | France | 1 | 2026 | 40 | 0.060 |
Why?
| | Iron | 1 | 2008 | 359 | 0.060 |
Why?
| | Ethics, Research | 1 | 2005 | 32 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 340 | 0.060 |
Why?
| | Personnel Selection | 1 | 2006 | 90 | 0.060 |
Why?
| | Organ Size | 3 | 2013 | 463 | 0.050 |
Why?
| | Knee Joint | 1 | 1989 | 439 | 0.050 |
Why?
| | Hospitalization | 3 | 2021 | 2468 | 0.050 |
Why?
| | Kidney Transplantation | 1 | 2011 | 702 | 0.050 |
Why?
| | Decision Making | 1 | 2012 | 987 | 0.050 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 121 | 0.050 |
Why?
| | Heart Failure | 1 | 2018 | 2323 | 0.050 |
Why?
| | Postmenopause | 1 | 2007 | 394 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1269 | 0.050 |
Why?
| | Odds Ratio | 2 | 2017 | 1070 | 0.050 |
Why?
| | Dose-Response Relationship, Radiation | 3 | 2008 | 141 | 0.050 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2003 | 18 | 0.050 |
Why?
| | Pilot Projects | 4 | 2009 | 1878 | 0.050 |
Why?
| | Ischemia | 1 | 2006 | 421 | 0.050 |
Why?
| | Iliac Vein | 1 | 2023 | 13 | 0.050 |
Why?
| | Illinois | 3 | 2009 | 47 | 0.050 |
Why?
| | Femoral Vein | 1 | 2023 | 36 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2006 | 353 | 0.050 |
Why?
| | Aneurysm, False | 2 | 2000 | 45 | 0.050 |
Why?
| | Menisci, Tibial | 2 | 1995 | 78 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 90 | 0.040 |
Why?
| | Elasticity | 1 | 2022 | 187 | 0.040 |
Why?
| | Pelvis | 1 | 2002 | 129 | 0.040 |
Why?
| | Drug Stability | 2 | 2013 | 168 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2013 | 328 | 0.040 |
Why?
| | World Health Organization | 2 | 2012 | 103 | 0.040 |
Why?
| | Hepatectomy | 2 | 2013 | 254 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 870 | 0.040 |
Why?
| | Feasibility Studies | 3 | 2011 | 1125 | 0.040 |
Why?
| | Osseointegration | 1 | 2021 | 60 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2021 | 114 | 0.040 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2021 | 59 | 0.040 |
Why?
| | Europe | 2 | 2012 | 420 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 627 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 360 | 0.040 |
Why?
| | Allografts | 1 | 2021 | 148 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 28 | 0.040 |
Why?
| | Carotid Artery, Internal | 1 | 2000 | 45 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 45 | 0.040 |
Why?
| | Neural Crest | 1 | 2021 | 130 | 0.040 |
Why?
| | Skull | 1 | 2021 | 162 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2013 | 777 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2021 | 326 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 61 | 0.040 |
Why?
| | Hepatic Encephalopathy | 1 | 1999 | 24 | 0.040 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 727 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 79 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2000 | 145 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 598 | 0.040 |
Why?
| | Tomography, Emission-Computed | 2 | 2009 | 71 | 0.040 |
Why?
| | Tracheoesophageal Fistula | 1 | 1999 | 38 | 0.030 |
Why?
| | Liver Failure | 1 | 1999 | 75 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2011 | 1293 | 0.030 |
Why?
| | Serum Albumin | 1 | 1999 | 147 | 0.030 |
Why?
| | Equipment Design | 2 | 2012 | 519 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 161 | 0.030 |
Why?
| | Streptokinase | 1 | 1998 | 9 | 0.030 |
Why?
| | Multiple Organ Failure | 1 | 1999 | 122 | 0.030 |
Why?
| | Ethiodized Oil | 2 | 2008 | 10 | 0.030 |
Why?
| | Mitomycin | 2 | 2008 | 31 | 0.030 |
Why?
| | Swine | 2 | 2016 | 821 | 0.030 |
Why?
| | Population Surveillance | 1 | 2001 | 477 | 0.030 |
Why?
| | Postoperative Hemorrhage | 1 | 1999 | 105 | 0.030 |
Why?
| | Guidelines as Topic | 2 | 2010 | 267 | 0.030 |
Why?
| | Nervous System Diseases | 2 | 2017 | 286 | 0.030 |
Why?
| | Cartilage Diseases | 2 | 1995 | 45 | 0.030 |
Why?
| | Intracranial Hypertension | 1 | 1997 | 42 | 0.030 |
Why?
| | Cause of Death | 1 | 1999 | 455 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 1998 | 122 | 0.030 |
Why?
| | Demography | 1 | 2017 | 274 | 0.030 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1997 | 130 | 0.030 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1997 | 127 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 174 | 0.030 |
Why?
| | Databases as Topic | 2 | 2010 | 70 | 0.030 |
Why?
| | Positron-Emission Tomography | 2 | 2008 | 342 | 0.030 |
Why?
| | Recovery of Function | 1 | 2000 | 721 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3633 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 337 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 302 | 0.030 |
Why?
| | Lung | 1 | 2008 | 4119 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 194 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 538 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 627 | 0.030 |
Why?
| | Phantoms, Imaging | 2 | 2008 | 159 | 0.030 |
Why?
| | Cysts | 1 | 1995 | 108 | 0.030 |
Why?
| | Embolism | 2 | 2008 | 49 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 561 | 0.030 |
Why?
| | Preoperative Care | 1 | 2016 | 375 | 0.020 |
Why?
| | Ablation Techniques | 1 | 2013 | 36 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2021 | 1979 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 2016 | 341 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2013 | 72 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 222 | 0.020 |
Why?
| | Scapula | 1 | 1992 | 48 | 0.020 |
Why?
| | Nausea | 1 | 2011 | 111 | 0.020 |
Why?
| | Muscular Diseases | 1 | 1992 | 110 | 0.020 |
Why?
| | Vomiting | 1 | 2011 | 131 | 0.020 |
Why?
| | International Agencies | 1 | 2010 | 30 | 0.020 |
Why?
| | Biomarkers | 2 | 2014 | 4329 | 0.020 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2010 | 74 | 0.020 |
Why?
| | Diarrhea | 1 | 2011 | 190 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2011 | 148 | 0.020 |
Why?
| | Standard of Care | 1 | 2010 | 81 | 0.020 |
Why?
| | Yttrium Isotopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Risk Assessment | 2 | 2009 | 3678 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2013 | 474 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 144 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 319 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5875 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3321 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1824 | 0.020 |
Why?
| | Fatigue | 1 | 2011 | 362 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 1992 | 437 | 0.020 |
Why?
| | Fibula | 1 | 1989 | 36 | 0.020 |
Why?
| | Registries | 1 | 2018 | 2382 | 0.020 |
Why?
| | Ligaments, Articular | 1 | 1989 | 56 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 253 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 613 | 0.020 |
Why?
| | Rhenium | 1 | 2008 | 3 | 0.020 |
Why?
| | Iohexol | 1 | 2008 | 23 | 0.020 |
Why?
| | Radioisotopes | 1 | 2008 | 37 | 0.020 |
Why?
| | Body Burden | 1 | 2007 | 7 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 334 | 0.020 |
Why?
| | Hysterosalpingography | 1 | 2007 | 9 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 994 | 0.020 |
Why?
| | Tibia | 1 | 1989 | 177 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2533 | 0.020 |
Why?
| | Hindlimb | 1 | 2008 | 128 | 0.020 |
Why?
| | Injections | 1 | 2008 | 199 | 0.020 |
Why?
| | Mesenteric Arteries | 1 | 2007 | 17 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2007 | 124 | 0.020 |
Why?
| | Celiac Artery | 1 | 2007 | 19 | 0.020 |
Why?
| | Femur | 1 | 1989 | 261 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 88 | 0.020 |
Why?
| | Injury Severity Score | 2 | 2000 | 571 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 878 | 0.010 |
Why?
| | Weight Loss | 1 | 2011 | 857 | 0.010 |
Why?
| | Retreatment | 1 | 2005 | 79 | 0.010 |
Why?
| | Cartilage, Articular | 1 | 1989 | 349 | 0.010 |
Why?
| | Rats | 1 | 2013 | 5574 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2007 | 693 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1754 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1843 | 0.010 |
Why?
| | Mice | 1 | 2021 | 18266 | 0.010 |
Why?
| | Child | 3 | 2017 | 22638 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11888 | 0.010 |
Why?
| | Radiography, Abdominal | 1 | 2001 | 44 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2002 | 419 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 386 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 82 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2000 | 51 | 0.010 |
Why?
| | Pneumonia, Aspiration | 1 | 1999 | 16 | 0.010 |
Why?
| | Hematoma | 1 | 1999 | 62 | 0.010 |
Why?
| | Veins | 1 | 1999 | 68 | 0.010 |
Why?
| | Endoscopy | 1 | 2001 | 316 | 0.010 |
Why?
| | Decision Trees | 1 | 1998 | 75 | 0.010 |
Why?
| | Aortic Diseases | 1 | 2000 | 124 | 0.010 |
Why?
| | Esophageal Stenosis | 1 | 1999 | 60 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 76 | 0.010 |
Why?
| | Arm | 1 | 1999 | 110 | 0.010 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1999 | 133 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1997 | 57 | 0.010 |
Why?
| | Cerebral Infarction | 1 | 1997 | 46 | 0.010 |
Why?
| | Los Angeles | 1 | 1997 | 73 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1997 | 129 | 0.010 |
Why?
| | Carotid Artery Diseases | 1 | 1997 | 70 | 0.010 |
Why?
| | Intracranial Pressure | 1 | 1997 | 64 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1998 | 279 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 212 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1997 | 211 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1997 | 92 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1997 | 118 | 0.010 |
Why?
| | Carotid Stenosis | 1 | 1997 | 103 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1997 | 206 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1997 | 319 | 0.010 |
Why?
| | Heparin | 1 | 1997 | 246 | 0.010 |
Why?
| | HIV | 1 | 1997 | 249 | 0.010 |
Why?
| | Cluster Analysis | 1 | 1997 | 494 | 0.010 |
Why?
| | Synovial Cyst | 1 | 1995 | 4 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1997 | 173 | 0.010 |
Why?
| | DNA, Viral | 1 | 1997 | 352 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1997 | 325 | 0.010 |
Why?
| | Brain Ischemia | 1 | 1997 | 362 | 0.010 |
Why?
| | Brain Injuries | 1 | 1997 | 499 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2002 | 6050 | 0.000 |
Why?
| | Tibial Meniscus Injuries | 1 | 1990 | 62 | 0.000 |
Why?
| | Postoperative Period | 1 | 1990 | 344 | 0.000 |
Why?
|
|
Ryu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|